Risques d’infections lors d’une transfusion sanguine
| dc.contributor.author | RAHMOUNI, Nor Elhouda | |
| dc.contributor.author | LATIGUI, YASMINA | |
| dc.date.accessioned | 2019-11-05T13:30:47Z | |
| dc.date.available | 2019-11-05T13:30:47Z | |
| dc.date.issued | 2019-09-29 | |
| dc.description.abstract | In recent years considerable progress has been made in order to guarantee maximum security for the transfused. However, a residual risk remains, that of contracting a viral disease by transfusion, despite donor selection measures. The risk occurs when the donor is in the seroconversion phase, a time when biological markers of viral pathology are undetectable by routine serologic diagnostic methods. The results obtained show that in a population of 96 hemodialysis recipients the percentages were: HIV0%; HBs25% .HCV.6%. TPHA .33% in men compared to HIV0%; HBs75% .HCV.67%. TPHA.3% in women. Nevertheless, these results show that the study population was infected with syphilis (4%), HCV (19%), HBs (4%) and HIV (0%). Having an effective health system for the detection of the disease transmissible by the blood is a good thing, the organization of this system for a preventive fight and a psychological support to the patients whatever the results of the test, without forgetting that this Last must be individualized because there is not a standard method that would be suitable in all situations. | en_US |
| dc.identifier.uri | http://e-biblio.univ-mosta.dz/handle/123456789/13564 | |
| dc.language.iso | fr | en_US |
| dc.subject | contracting a viral | en_US |
| dc.subject | transfusion | en_US |
| dc.subject | the seroconversion phase | en_US |
| dc.subject | viral pathology | en_US |
| dc.subject | HIV | en_US |
| dc.subject | HCV | en_US |
| dc.subject | the blood | en_US |
| dc.title | Risques d’infections lors d’une transfusion sanguine | en_US |
| dc.type | Other | en_US |